NVAX Jan 2025 0.500 put
OPR - OPR Delayed Price. Currency in USD
Add to watchlist
At close: 03:12PM EDT
| Previous Close | 0.0300 |
| Open | N/A |
| Bid | 0.0000 |
| Ask | 0.1100 |
| Strike | 0.50 |
| Expire Date | 2025-01-17 |
| Day's Range | 0.0300 - 0.0300 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 3 |
PR NewswireNovavax to Participate in 2024 Jefferies Global Healthcare Conference
Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced it will participate in the 2024 Jefferies Global Healthcare Conference.
ZacksHere is What to Know Beyond Why Novavax, Inc. (NVAX) is a Trending Stock
Zacks.com users have recently been watching Novavax (NVAX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Barrons.comArbutus, Novavax See Activist Investor Action
Whitefort Capital wants biopharmaceutical firm Arbutus to stop issuing stock. Shah Capital ended a proxy campaign against biotech Novavax.
© 2024 Yahoo. All rights reserved.